DJIA 17,156.85 24.88 0.15%
NASDAQ 4,562.19 9.43 0.21%
S&P 500 2,001.57 2.59 0.13%
market minute promo

162.30 -2.05 (-1.25%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

JAZZ $162.30 -1.25%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $165.47
Previous Close $164.35
Daily Range $160.52 - $166.13
52-Week Range $80.40 - $176.60
Market Cap $9.8B
P/E Ratio 127.40
Dividend (Yield) $0.00 (0.0%)
Volume 724,010
Average Daily Volume 1,135,506
Current FY EPS $7.40

Sector

Healthcare

Industry

Drugs

Jazz Pharmaceuticals, Inc. (JAZZ) Description

A specialty pharmaceutical company, which focused on identifying, developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry. Website: http://www.jazzpharma.com/

News & Commentary Rss Feed

Should You Invest in Corporate Tax Inversions?

Despite the controversy regarding whether corporate inversions are right or wrong, investors are looking to make money from them. Has Motif Investing put together a way for small investors to profit from tax inversions?

Insider Trading Alert - TDC, MJN And JAZZ Traded By Insiders

Jazz Pharmaceuticals (JAZZ) in Focus: Stock Rises 7.1% - Tale of the Tape

Jazz Pharmaceuticals (JAZZ) in Focus: Stock Rises 7.1% - Tale of the Tape

Pfizer: You Won't Fool Me Twice

Jazz Pharmaceuticals Up On Allergan, Inc. Rumor

Jazz Pharmaceuticals: Growth Trajectory Can Continue In Future

Three Stocks Top-Performing Funds Like: Facebook Baidu Gilead

Jazz Pharmaceuticals (JAZZ) Shares March Higher, Can It Continue? - Tale of the Tape

Jazz Pharmaceuticals (JAZZ) Shares March Higher, Can It Continue? - Tale of the Tape

Dow Flirts With 19,000, S&P 500 Approaches 2,000 & Nasdaq Trading At 14-Year Highs

JP Morgan Says Jazz Pharmaceuticals Positioned For 'Organic Growth And Acquisition'

See More JAZZ News...

JAZZ's Top Competitors

JAZZ $162.30 (-1.25%)
Current stock: JAZZ
JNJ $106.19 (0.29%)
Current stock: JNJ
NVS $94.72 (0.36%)
Current stock: NVS
RHHBY $37.37 (-0.31%)
Current stock: RHHBY